1. Home
  2. VIR vs NAT Comparison

VIR vs NAT Comparison

Compare VIR & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • NAT
  • Stock Information
  • Founded
  • VIR 2016
  • NAT 1995
  • Country
  • VIR United States
  • NAT Bermuda
  • Employees
  • VIR N/A
  • NAT N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • NAT Marine Transportation
  • Sector
  • VIR Health Care
  • NAT Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • NAT Nasdaq
  • Market Cap
  • VIR 706.4M
  • NAT 669.1M
  • IPO Year
  • VIR 2019
  • NAT 1997
  • Fundamental
  • Price
  • VIR $5.63
  • NAT $3.22
  • Analyst Decision
  • VIR Strong Buy
  • NAT Hold
  • Analyst Count
  • VIR 11
  • NAT 1
  • Target Price
  • VIR $25.73
  • NAT $3.00
  • AVG Volume (30 Days)
  • VIR 1.1M
  • NAT 3.0M
  • Earning Date
  • VIR 10-30-2025
  • NAT 08-28-2025
  • Dividend Yield
  • VIR N/A
  • NAT 10.48%
  • EPS Growth
  • VIR N/A
  • NAT N/A
  • EPS
  • VIR N/A
  • NAT 0.06
  • Revenue
  • VIR $19,000,000.00
  • NAT $301,169,000.00
  • Revenue This Year
  • VIR N/A
  • NAT N/A
  • Revenue Next Year
  • VIR $15.25
  • NAT $38.51
  • P/E Ratio
  • VIR N/A
  • NAT $53.87
  • Revenue Growth
  • VIR N/A
  • NAT N/A
  • 52 Week Low
  • VIR $4.16
  • NAT $2.13
  • 52 Week High
  • VIR $14.45
  • NAT $3.83
  • Technical
  • Relative Strength Index (RSI)
  • VIR 59.22
  • NAT 51.81
  • Support Level
  • VIR $5.36
  • NAT $3.06
  • Resistance Level
  • VIR $6.00
  • NAT $3.38
  • Average True Range (ATR)
  • VIR 0.28
  • NAT 0.10
  • MACD
  • VIR 0.03
  • NAT -0.01
  • Stochastic Oscillator
  • VIR 65.62
  • NAT 52.92

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

Share on Social Networks: